tradingkey.logo
tradingkey.logo
Suchen

Heartbeam Inc

BEAT
Zur Watchlist hinzufügen
0.750USD
+0.097+14.80%
Handelsschluss 06/30, 16:00ETKurse um 15 Minuten verzögert
30.85MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Heartbeam Inc Unternehmen

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.

Heartbeam Inc Informationen

BörsenkürzelBEAT
Name des UnternehmensHeartbeam Inc
IPO-datumOct 14, 2021
CEOEno (Robert P)
Anzahl der mitarbeiter21
WertpapierartOrdinary Share
GeschäftsjahresendeOct 14
Addresse2118 Walsh Ave., Suite 210
StadtSANTA CLARA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl95050
Telefon14088994443
Websitehttps://www.heartbeam.com/
BörsenkürzelBEAT
IPO-datumOct 14, 2021
CEOEno (Robert P)

Führungskräfte von Heartbeam Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Branislav Vajdic, Ph.D.
Dr. Branislav Vajdic, Ph.D.
President, Founder, Director
President, Founder, Director
941.35K
-0.14%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board and Independent Director
Executive Chairman of the Board and Independent Director
476.87K
+26.13%
Ms. Marga Ortigas-Wedekind
Ms. Marga Ortigas-Wedekind
Independent Director
Independent Director
214.60K
+28.18%
Mr. Timothy (Tim) Cruickshank
Mr. Timothy (Tim) Cruickshank
Chief Financial Officer
Chief Financial Officer
72.23K
+32.30%
Mr. George A. de Urioste
Mr. George A. de Urioste
Independent Director
Independent Director
--
--
Mr. Willem P. Elfrink
Mr. Willem P. Elfrink
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President - MZ North America
Executive Vice President - MZ North America
--
--
Mr. Kenneth Persen
Mr. Kenneth Persen
Chief System Deployment Officer
Chief System Deployment Officer
--
--
Mr. Robert P. (Rob) Eno
Mr. Robert P. (Rob) Eno
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Mark E. Strome
Mr. Mark E. Strome
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Branislav Vajdic, Ph.D.
Dr. Branislav Vajdic, Ph.D.
President, Founder, Director
President, Founder, Director
941.35K
-0.14%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board and Independent Director
Executive Chairman of the Board and Independent Director
476.87K
+26.13%
Ms. Marga Ortigas-Wedekind
Ms. Marga Ortigas-Wedekind
Independent Director
Independent Director
214.60K
+28.18%
Mr. Timothy (Tim) Cruickshank
Mr. Timothy (Tim) Cruickshank
Chief Financial Officer
Chief Financial Officer
72.23K
+32.30%
Mr. George A. de Urioste
Mr. George A. de Urioste
Independent Director
Independent Director
--
--
Mr. Willem P. Elfrink
Mr. Willem P. Elfrink
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Heartbeam Inc?

Die fünf größten Anteilseigner von Heartbeam Inc sind: Dr. Branislav Vajdic, Ph.D.

Wie viele Institutionen halten Anteile an Heartbeam Inc (BEAT)?

Mit Stand vom 2026Q1 halten 72 Institutionen Anteile an Heartbeam Inc, mit einem Gesamtmarktwert von etwa 4.50M, was 8.40% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 238635.00 gestiegen.
KeyAI